Koa Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.3M Sell
92,992
-1,341
-1% -$130K 6.65% 5
2026
Q2
$7.38M Buy
94,333
+511
+0.5% +$34.8K 5.02% 5
2026
Q1
$6.06M Buy
93,822
+714
+0.8% +$50.3K 4.38% 5
2025
Q4
$6.27M Buy
93,108
+6,465
+7% +$435K 4.3% 5
2025
Q3
$6.35M Sell
86,643
-3,878
-4% -$258K 4.71% 4
2025
Q2
$4.71M Buy
90,521
+5,043
+6% +$287K 3.74% 6
2025
Q1
$5.45M Buy
85,478
+3,071
+4% +$178K 4.4% 5
2024
Q4
$3.94M Buy
82,407
+7,924
+11% +$406K 3.22% 6
2024
Q3
$4.26M Buy
74,483
+915
+1% +$52.5K 3.29% 8
2024
Q2
$3.85M Sell
73,568
-848
-1% -$37.2K 3.26% 8
2024
Q1
$3.03M Buy
74,416
+9,503
+15% +$356K 2.73% 11
2023
Q4
$2.4M Buy
+64,913
New +$2.44M 2.37% 14

Other funds holding HALO

Koa Wealth Management's HALO Position: Q3 2026 in Review

Koa Wealth Management reduced its Halozyme (HALO) stake by 1.4% in Q3 2026, selling an estimated $130K and leaving 92,992 shares worth $10.3M. The position accounts for 6.65% of the portfolio, ranked #5.

Koa Wealth Management first reported a position in HALO in Q4 2023 and has held it in 12 quarters since. 249 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Koa Wealth Management held 92,992 shares of Halozyme worth $10.3M as of Q3 2026.
  • Koa Wealth Management sold 1,341 Halozyme shares in Q3 2026, an estimated $130K.
  • Halozyme made up 6.65% of Koa Wealth Management's portfolio in Q3 2026, its #5 holding.
  • Koa Wealth Management first reported a position in Halozyme in Q4 2023 and has held it in 12 quarters since.
  • 249 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Koa Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.